At the end of the latest market close, Biora Therapeutics Inc. (BIOR) was valued at $0.61. In that particular session, Stock kicked-off at the price of $0.611 while reaching the peak value of $0.65 and lowest value recorded on the day was $0.583. The stock current value is $0.62.Recently in News on September 13, 2022, Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists. Patent Covers Jet Delivery of GLP-1 Receptor Agonists to the Small Intestine for Treatment of Any Disease Including Type 2 Diabetes. You can read further details here
Biora Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3100 on 01/04/22, with the lowest value was $0.5600 for the same time period, recorded on 06/14/22.
Biora Therapeutics Inc. (BIOR) full year performance was -32.67%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Biora Therapeutics Inc. shares are logging -90.00% during the 52-week period from high price, and 10.71% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.56 and $6.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 980269 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Biora Therapeutics Inc. (BIOR) recorded performance in the market was -70.33%, having the revenues showcasing 0.10% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 120.19M, as it employees total of 124 workers.
The Analysts eye on Biora Therapeutics Inc. (BIOR)
During the last month, 0 analysts gave the Biora Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7490, with a change in the price was noted -0.23. In a similar fashion, Biora Therapeutics Inc. posted a movement of -27.32% for the period of last 100 days, recording 2,063,571 in trading volumes.
Technical rundown of Biora Therapeutics Inc. (BIOR)
Raw Stochastic average of Biora Therapeutics Inc. in the period of last 50 days is set at 6.53%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 12.05%. In the last 20 days, the company’s Stochastic %K was 5.26% and its Stochastic %D was recorded 4.12%.
Considering, the past performance of Biora Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -70.33%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -61.25%, alongside a downfall of -32.67% for the period of the last 12 months. The shares increased approximately by -7.89% in the 7-day charts and went up by -25.69% in the period of the last 30 days. Common stock shares were driven by 0.10% during last recorded quarter.